MM

Madan Mohan Reddy Mettu

Active Director Whole-Time Director DIN 01284266
DIN 01284266 First appointment Nov 2009 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 11 active board seats
Past companies 13 historical roles
Total affiliations 24 Since Nov 2009
Shareholding value Locked Premium profile

About Madan Mohan Reddy Mettu

Madan Mohan Reddy Mettu has 16 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 11 companies, including Aurobindo Pharma Ltd and Curateq Biologics Private Limited. Formerly with 13 companies, such as Pravesha Industries Private Limited and Gls Pharma Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01284266
Primary Designation Whole-Time Director
First Appointment 13 Nov 2009
Oldest Company Age 39 yrs

Current companies

Company Designation Appointment Founded Status
Aurobindo Pharma Ltd L24239TG1986PLC015190
Whole-Time Director 01 Jan 2013 1986 Active
Curateq Biologics Private Limited U24110TG2020PTC140190
Director 25 Apr 2020 2020 Active
Eugia Steriles Private Limited U24239TG2020PTC141428
Director 05 Jul 2020 2020 Active
Eugia Pharma Specialities Limited U24297TG2013PLC087048
Director 17 Apr 2013 2013 Active
Auro Vaccines Private Limited U24297TG2021PTC156684
Director 08 Nov 2021 2021 Active
Aurozest Private Limited U24299TG2020PTC142578
Director 06 Aug 2020 2020 Active
Eugia Sez Private Limited U24299TG2021PTC148856
Director 20 Feb 2021 2021 Active
Mmr Family Advisors Private Limited U66190TS2025PTC197401
Director 21 Apr 2025 2025 Active

Previous companies

Company Designation Appointment Founded Status
Pravesha Industries Private Limited U29219HR1993PTC137431
Director 01 Mar 2014 1993 Active
Gls Pharma Limited U24239TS2004PLC184306
Director 01 Jul 2022 2004 Active
Aurozymes Limited U24232TG2013PLC091383
Director 30 Mar 2015 2013 Amalgamated
Sgd Pharma India Private Limited U26100TG2009PTC065810
Director 13 Nov 2009 2009 Active
Raidurgam Developers Limited U45100TG2012PLC081892
Director 30 Mar 2015 2012 Active
Apl Research Centre Limited U24116TG2006PLC051171
Director 30 Mar 2015 2006 Amalgamated
Director 03 Sep 2010 2010 Active
Director 03 Mar 2016 2004 Active
Curepro Parenterals Limited U24232TG2013PLC087101
Director 21 Aug 2013 2013 Amalgamated
Oremsi Plastics Private Limited U25203TG2012PTC084731
Director 11 Dec 2012 2012 Strike Off
Auronext Pharma Private Limited U74999TG2009PTC109591
Director 31 Aug 2020 2009 Amalgamated
Designated Partner 25 Aug 2016 2016 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aurobindo Pharma Ltd
Curateq Biologics Private Limited
Curepro Parenterals Limited
Eugia Steriles Private Limited
Premium access

Shareholding and investment profile for Madan Mohan Reddy Mettu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madan Mohan Reddy Mettu

Madan Mohan Reddy Mettu has 16 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 11 companies, including Aurobindo Pharma Ltd and Curateq Biologics Private Limited. Formerly with 13 companies, such as Pravesha Industries Private Limited and Gls Pharma Limited. Engaged in General Business. Contributes to corporate operations.

Madan Mohan Reddy Mettu is associated with 11 companies as Whole-Time Director and Director.

Madan Mohan Reddy Mettu has expertise in General Business.

Madan Mohan Reddy Mettu has 16 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available